Asymchem Laboratories Tianjin Co Ltd Class A 002821
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 002821 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CNY 78.98
- Day Range
- CNY 76.72–79.22
- 52-Week Range
- CNY 74.91–165.27
- Bid/Ask
- CNY 77.29 / CNY 77.30
- Market Cap
- CNY 28.56 Bil
- Volume/Avg
- 4.2 Mil / 5.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 15.95
- Price/Sales
- 4.12
- Dividend Yield (Trailing)
- 2.22%
- Dividend Yield (Forward)
- 2.22%
- Total Yield
- 2.33%
Company Profile
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Large Core
- Total Number of Employees
- 9,788
- Website
- https://www.asymchem.com
Comparables
Valuation
|
Metric
|
002821
|
688687
|
301230
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.95 | 39.32 | 239.75 |
Price/Book Value | 1.66 | 2.79 | 3.30 |
Price/Sales | 4.12 | 3.34 | 7.50 |
Price/Cash Flow | 10.49 | 24.32 | 225.78 |
Price/Earnings
002821
688687
301230
Financial Strength
|
Metric
|
002821
|
688687
|
301230
|
|---|---|---|---|
Quick Ratio | 6.12 | 3.17 | 3.44 |
Current Ratio | 6.85 | 3.52 | 3.96 |
Interest Coverage | 329.44 | 173.44 | 2.98 |
Quick Ratio
002821
688687
301230
Profitability
|
Metric
|
002821
|
688687
|
301230
|
|---|---|---|---|
Return on Assets (Normalized) | 8.96% | 5.30% | 1.10% |
Return on Equity (Normalized) | 10.17% | 7.05% | 1.40% |
Return on Invested Capital (Normalized) | 9.46% | 5.78% | 1.15% |
Return on Assets
002821
688687
301230
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Krflldbhz | Yyz | $605.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Czspzpq | Pxtrgs | $116.3 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Trgsrqtk | Znthtr | $108.5 Bil | |
MRNA
| Moderna Inc | Gjcksbbfs | Nyrq | $62.9 Bil | |
BNTX
| BioNTech SE ADR | Ywsvpcklt | Tfvl | $23.9 Bil | |
ARGX
| argenx SE ADR | Mmqlypp | Fwwv | $21.6 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Khymmnyw | Jfnmnb | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Xnypqqgn | Zpwzk | $14.3 Bil | |
INCY
| Incyte Corp | Fhybwsnvj | Xmylr | $12.9 Bil | |
UTHR
| United Therapeutics Corp | Vszbyldmn | Nfwk | $12.1 Bil |